Skip to main content
An official website of the United States government

Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Patients with Metastatic Renal Cell Carcinoma

Trial Status: administratively complete

This clinical trial determines how well arterial spin labeled (ASL) magnetic resonance imaging (MRI) works in detecting treatment response in patients with kidney cancer that has spread to other places in the body (metastatic). ASL MRI is a way to measure blood flow in the body without using contrast agents, and may be more effective than standard imaging in detecting treatment response in patients with kidney cancer.